Abstract
Purpose
Restriction fragment length polymorphism (RFLP) and enzyme-linked immunosorbent assay (ELISA) with monoclonal antibodies (mAbs) were used in this study to detect genotypes of HBV, and the efficiency and precision of ELISA using the mAbs for HBV genotype detection were also estimated.
Methods
The ELISA with mAbs method was used for the detection of HBV genotype in a Taiwanese population. The HBV genotypes of 100 chronic hepatitis B patients were determined by ELISA and were then compared with those obtained using RFLP.
Results
Genotype B was found to be the most prevalent in this study (63% by RFLP; 62% by ELISA) followed by genotype C (31% by RFLP; 35% by ELISA). There was no significant difference between the results obtained by RFLP and ELISA (P = 0.75). The ELISA overall genotypeable rate, the correct genotyping rate from genotypeable specimens, and the concordance of the HBV genotyping assay was 96.00, 94.79, and 91.00%; for the ELISA HBV genotyping assay for genotype B specimens was 96.77, 100.00, and 96.77%; and for genotype C specimens was 97.14, 91.18, and 88.57%, respectively. The mean HBV DNA level was higher in the specimens that could be genotyped by both RFLP and ELISA samples (6.24 ± 1.77 vs. 2.34 ± 0.90, log IU/ml), and a significant difference in terms of HBV DNA level of more than 2 × 103 IU/ml was identified between the genotyped RFLP samples (P < 0.001).
Conclusions
ELISA is a practical and a useful method for HBV genotyping in a clinical setting in Taiwan, in particular for patients with lower levels of HBV DNA.
Similar content being viewed by others
References
Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97–107
Lok AS. Chronic hepatitis B. N Engl J Med 2002;346:1682–1683
Szabo E, Paska C, Kaposi Novak P, Schaff Z, Kiss A. Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis. Pathol Oncol Res 2004;10:5–11
Anthony PP. Hepatocellular carcinoma: an overview. Histopathology 2001;39:109–118
Okuda K. Hepatocellular carcinoma. J Hepatol 2000;32:225–237
Courouce-Pauty AM, Plancon A, Soulier JP. Distribution of HBsAg subtypes in the world. Vox Sang 1983;44:197–211
Norder H, Courouce AM, Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994;198:489–503
Okamoto H, Imai M, Usuda S, Tanaka E, Tachibana K, Mishiro S, et al. Hemagglutination assay of polypeptide coded by the pre-S region of hepatitis B virus DNA with monoclonal antibody: correlation of pre-S polypeptide with the receptor for polymerized human serum albumin in serums containing hepatitis B antigens. J Immunol 1985;134:1212–1216
Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 1988;69(Pt 10):2575–2583
FKaY Tanaka, Kramvis A, Simmonds P, Mizokami M. When Should “I” consider a new hepatitis B virus genotype? J Virol 2008;82:8241–8242
Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol 2009;83:10538–10547
Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 2002;83:2059–2073
Vieth S, Manegold C, Drosten C, Nippraschk T, Gunther S. Sequence and phylogenetic analysis of hepatitis B virus genotype G isolated in Germany. Virus Genes 2002;24:153–156
Kao JH. Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol 2002;17:643–650
Kao JH, Wu NH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes and the response to interferon therapy. J Hepatol 2000;33:998–1002
Wai CT, Chu CJ, Hussain M, Lok AS. HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C. Hepatology 2002;36:1425–1430
Erhardt A, Blondin D, Hauck K, Sagir A, Kohnle T, Heintges T, et al. Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D. Gut 2005;54:1009–1013
Kao JH, Liu CJ, Chen DS. Hepatitis B viral genotypes and lamivudine resistance. J Hepatol 2002;36:303–304
Palumbo E. Hepatitis B genotypes and response to antiviral therapy: a review. Am J Ther 2007;14:306–309
Kao JH, Chen PJ, Lai MY, Chen DS. Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection. J Clin Microbiol 2002;40:1207–1209
Lindh M, Andersson AS, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus–large-scale analysis using a new genotyping method. J Infect Dis 1997;175:1285–1293
Repp R, Rhiel S, Heermann KH, Schaefer S, Keller C, Ndumbe P, et al. Genotyping by multiplex polymerase chain reaction for detection of endemic hepatitis B virus transmission. J Clin Microbiol 1993;31:1095–1102
Mizokami M, Nakano T, Orito E, Tanaka Y, Sakugawa H, Mukaide M, et al. Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns. FEBS Lett 1999;450:66–71
Usuda S, Okamoto H, Iwanari H, Baba K, Tsuda F, Miyakawa Y, et al. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J Virol Methods 1999;80:97–112
Mizuochi T, Okada Y, Umemori K, Mizusawa S, Sato S, Yamaguchi K. Reactivity of genotypically distinct hepatitis B virus surface antigens in 10 commercial diagnostic kits available in Japan. Jpn J Infect Dis 2005;58:83–87
Yu ML, Wang LY, Chuang WL, Dai CY, Sung MH, Chen SC, et al. Serotyping and genotyping of hepatitis C virus in Taiwanese patients with type C chronic liver disease and uraemic patients on maintenance haemodialysis. J Gastroenterol Hepatol 2000;15:792–797
Tanaka Y, Sugauchi F, Matsuuraa K, Naganuma H, Tatematsu K, Takagi K, et al. Evaluation of hepatitis B virus genotyping EIA kit. Rinsho Byori 2009;57:42–47
Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463–5467
Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 1985;317:489–495
Mizokami M, Orito E, Ohba K, Ikeo K, Lau JY, Gojobori T. Constrained evolution with respect to gene overlap of hepatitis B virus. J Mol Evol 1997;44(Suppl 1):S83–S90
Acknowledgements
This study was supported by grants from the Taiwan Liver Research Foundation, Taiwan.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
S.-F. Liu and M.-H. Hsieh contributed equally to this study.
Rights and permissions
About this article
Cite this article
Liu, SF., Hsieh, MH., Hou, NJ. et al. Hepatitis B virus genotyping by enzyme-linked immunosorbent assay in Taiwan. Hepatol Int 4, 601–607 (2010). https://doi.org/10.1007/s12072-010-9198-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12072-010-9198-y